Skip to content

A research study of a new medicine (NNC0650-0013) in healthy men

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506134-79-00
Acronym
NN9650-5027
Enrollment
60
Registered
2023-12-22
Start date
2024-01-23
Completion date
2024-05-07
Last updated
2023-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2; healthy subjects, Weight management

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026